Literature DB >> 18609558

Formation of microparticulate protein powder using a supercritical fluid antisolvent.

S D Yeo1, G B Lim, P G Debendetti, H Bernstein.   

Abstract

Gas antisolvent (GAS) expansion of dimethylsulfoxide (DMSO) and N,N-dimethylformamide (DMFA) solutions with supercritical carbon dioxide was used to produce biologically active powders of insulin. Powders with 90% of the particles smaller than 4 mum and 10% smaller than 1 mum were obtained under all conditions tested when the process was operated continuously, with small liquid droplets sprayed into a flowing supercritical continuum. Slow pressurization of the stagnant protein solution resulted in larger particles. In vivo tests on rats revealed no differences between the biological activity of processed and unprocessed insulin, GAS processing of organic solution appears to be a reliable and effective method for the production of dry, biologically active microparticulate powders of peptides and proteins. (c) 1993 John Wiley & Sons, Inc.

Entities:  

Year:  1993        PMID: 18609558     DOI: 10.1002/bit.260410308

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  18 in total

Review 1.  Phase behavioral effects on particle formation processes using supercritical fluids.

Authors:  S Palakodaty; P York
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Protein inhalation powders: spray drying vs spray freeze drying.

Authors:  Y F Maa; P A Nguyen; T Sweeney; S J Shire; C C Hsu
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

4.  Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.

Authors:  Yuh-Fun Maa; Mahmoud Ameri; Robert Rigney; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 5.  Stabilization of proteins in dry powder formulations using supercritical fluid technology.

Authors:  Natasa Jovanović; Andréanne Bouchard; Gerard W Hofland; Geert-Jan Witkamp; Daan J A Crommelin; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

6.  Stability improvement of a liquid enzyme product.

Authors:  Núria Jiménez; Maria Luisa Garcia; Javier Galán; Alberto Vallet; Geoffrey Owen; G Michael Wall
Journal:  AAPS PharmSciTech       Date:  2009-11-04       Impact factor: 3.246

7.  Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance.

Authors:  S Palakodaty; P York; J Pritchard
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 8.  Controlling the porosity and microarchitecture of hydrogels for tissue engineering.

Authors:  Nasim Annabi; Jason W Nichol; Xia Zhong; Chengdong Ji; Sandeep Koshy; Ali Khademhosseini; Fariba Dehghani
Journal:  Tissue Eng Part B Rev       Date:  2010-08       Impact factor: 6.389

9.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

10.  Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.

Authors:  Vipaluk Patomchaiviwat; Ornlaksana Paeratakul; Poj Kulvanich
Journal:  AAPS PharmSciTech       Date:  2008-11-07       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.